Foldax
Salt Lake City, US · Founded 2013 · 38 employees on LinkedIn · 4 known investors
Company advancing product and clinical development in the medical device space.
Founders & leadership
FM
Frank MaguireNamed on SEC filing
Board
KC
Ken CharhutBoard directorBoard Member; Executive Chairman of the Board, Foldax, Inc. at MemorialCare Innovation Fund
GW
George WallaceBoard director
MG
Morteza GharibBoard director
MG
Mory GharibBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$23.7M disclosed across 9 of 10 rounds · 2014–2023
▶$7MraisedNov 2023 · 10 investors · BiotechnologyRule 506(b)
▶$7MraisedNov 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott HuennekensDirector
- Ken CharhutDirector
- Jim DemetriadesDirector
- Scott RichlandDirector
- George WallaceDirector
- Greg CasciaroExecutive Officer, Director
- Brant HeiseDirector
- Amount sold
- $7M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MofferedJan 2022 · OtherRule 506(b)
▶$15MofferedJan 2022 · Other
Rule 506(b)Officers, directors & promoters on the filing
- James DemetriadesDirector
- George WallaceDirector
- Scott HuennekensDirector
- Renee MasiDirector
- Brant HeiseDirector
- Morteza GharibDirector
- Kenneth CharhutDirector
- Offering amount
- $15M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.3MraisedDec 2018 · 15 investors · Other TechnologyRule 506(b)
▶$10.3MraisedDec 2018 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jim DemetriadesDirector
- George WallaceDirector
- Ken CharhutDirector
- Frank MaguireExecutive Officer, Director
- Mory GharibDirector
- Renee MasiDirector
- Offering amount
- $10.3M
- Amount sold
- $10.3M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedMay 2017 · 1 investors · OtherRule 506(b)
▶$300KraisedMay 2017 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- George WallaceDirector
- James DemetriadesDirector
- Morteza GharibDirector
- Frank MaguireExecutive Officer, Director
- Ken CharhutDirector
- Offering amount
- $9M
- Amount sold
- $300K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$3.1MraisedJul 2016 · 9 investors · OtherRule 506(b)
▶$3.1MraisedJul 2016 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Frank MaguireExecutive Officer, Director
- Demetriades JamesDirector
- Ken CharhutDirector
- Morteza GharibDirector
- George WallaceDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2.5MraisedSep 2015 · 1 investors · OtherRule 506(b)
▶$2.5MraisedSep 2015 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Morteza GharibDirector
- Frank MaguireExecutive Officer, Director
- Ken CharhutDirector
- George WallaceDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$350KraisedJun 2015 · 2 investors · Other TechnologyRule 506(b)
▶$350KraisedJun 2015 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank MaguireExecutive Officer, Director
- George WallaceDirector
- Morteza GharibDirector
- Ken CharhutDirector
- Offering amount
- $1.5M
- Amount sold
- $350K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$50KraisedAug 2014 · 1 investors · OtherRule 506(b)
▶$50KraisedAug 2014 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ken CharhutDirector
- George WallaceDirector
- Mory GharibDirector
- Frank MaguireExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $50K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Rf Surgical25 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards Lifesciences25 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Boston Scientific24 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Cardiovalve14 shared keywordsCardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery. The device targets structural heart disease and is currently restricted to research use.
Companies competing with Foldax for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Foldax do?
- Company advancing product and clinical development in the medical device space.
- Who are Foldax's investors?
- Foldax's investors include Angel Physicians Fund, Kairos Venture Investments, Llc, MemorialCare Innovation Fund, Kairos Venture Partners.
- How much funding has Foldax raised?
- Foldax has disclosed $23.7M raised across 9 of its 10 known rounds.
- Where is Foldax headquartered?
- Foldax is headquartered in Salt Lake City, US.